BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28455149)

  • 1. Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base.
    Moreno AC; Verma V; Hofstetter WL; Lin SH
    J Thorac Oncol; 2017 Jul; 12(7):1152-1160. PubMed ID: 28455149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis.
    Moreno AC; Zhang N; Verma V; Giordano SH; Lin SH
    J Gastrointest Oncol; 2019 Feb; 10(1):74-84. PubMed ID: 30788162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Strahlenther Onkol; 2018 Feb; 194(2):116-124. PubMed ID: 28916906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
    Haque W; Verma V; Bernicker E; Butler EB; Teh BS
    Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
    Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study.
    Herrmann E; Mertineit N; De Bari B; Hoeng L; Caparotti F; Leiser D; Jumeau R; Cihoric N; Jensen AD; Aebersold DM; Ozsahin M
    Radiat Oncol; 2017 Jun; 12(1):97. PubMed ID: 28615060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer.
    Yang Y; Chen M; Xie J; Ji Y; Sheng L; Qiu G; Du X; Wei Q
    Front Oncol; 2022; 12():778898. PubMed ID: 35237508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.
    Lester SC; Lin SH; Chuong M; Bhooshan N; Liao Z; Arnett AL; James SE; Evans JD; Spears GM; Komaki R; Haddock MG; Mehta MP; Hallemeier CL; Merrell KW
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):820-828. PubMed ID: 28476435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
    Song T; Du D; Zhang X; Fang M; Wu S
    Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
    Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
    Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasion.
    Hamai Y; Hihara J; Emi M; Taomoto J; Aoki Y; Kishimoto I; Ibuki Y; Okada M
    Anticancer Res; 2013 Aug; 33(8):3495-502. PubMed ID: 23898125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
    Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
    Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?
    Lee A; Wong AT; Schwartz D; Weiner JP; Osborn VW; Schreiber D
    Ann Thorac Surg; 2016 Aug; 102(2):433-8. PubMed ID: 27154156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study.
    Piessen G; Messager M; Mirabel X; Briez N; Robb WB; Adenis A; Mariette C
    Ann Surg; 2013 Nov; 258(5):793-9; discussion 799-800. PubMed ID: 24096755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.